Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders 2024-10-21
  2. The investigation of protective effects of glucagon-like peptide-1 (GLP-1) analogue exenatide against glucose and fructose-induced neurotoxicity 2019-05-01
  3. [Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?] 2014-12-01

Studies

4 studies carry this tag.

Date range

2008 to 2024

Top journals

  • Cureus 1
  • Neurochemical research 1
  • Revista de neurologia 1
  • The International journal of neuroscience 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Glucagon-like peptide-1 (GLP-1) agonists have emerged as a groundbreaking class of medications for managing type 2 diabetes and associated metabolic disorders.

  2. The investigation of protective effects of glucagon-like peptide-1 (GLP-1) analogue exenatide against glucose and fructose-induced neurotoxicity

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. The International journal of neuroscience 2019-05-01 Drug development

    Diabetes mellitus (DM) is one of the most common metabolic disorders characterized by hyperglycemia due to insufficiency of insulin and/or insulin resistance.

  3. [Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?]

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Revista de neurologia 2014-12-01 Drug development

    The GLP-1 analogs have neuroprotective properties.

  4. Glucagon-like peptide-1 (GLP-1) diminishes neuronal degeneration and death caused by NGF deprivation by suppressing Bim induction

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurochemical research 2008-03-20 Drug development

    Glucagon-like peptide-1 (GLP-1) is a glucoincretin hormone most intensively studied for its actions on insulin secreting beta-cells.

All topic tags with their study counts